Validation of accelerometer cut-points for physical activity intensities in people with coronary heart disease.

A/Prof Nicole Freene0 sites164 target enrollmentJune 2, 2023

Overview

No summary available.

Registry

who.int

Start Date

June 2, 2023

End Date

TBD

Last Updated

2 years ago

Study Type

Observational

Sex

All

Sponsor

A/Prof Nicole Freene

•Participants will be eligible to take part in the study if they are aged 18\+, have stable coronary heart disease (CHD) and are receiving optimal medical treatment \+/\- revascularisation, that is, coronary artery bypass graft surgery (CABG), percutaneous coronary intervention (PCI), or have had a myocardial infarction (MI).

•Participants will be excluded if they have primary atrial fibrillation, New York Heart Association class III\-IV symptoms of heart failure (or documented signs and symptoms of chronic heart failure, with ejection fraction \< 45%), uncontrolled arrhythmias, severe chronic obstructive pulmonary disease, uncontrolled hypertension, symptomatic peripheral artery disease, unstable angina, uncontrolled diabetes, are unable to perform a maximal walking test on a treadmill, or are unable to wear an accelerometer due to disability, for example, if they are confined to a wheelchair. Medical clearance to participate in the study will be required from the participants cardiologist or cardiothoracic surgeon and/or the medical practitioner (Sports Physician) conducting the pre\-exercise screening. Eligible participants must have adequate language (English speaking only) and cognitive skills.